SIRPalpha-deficient macrophages orchestrate a potent antitumor immune response under radiotherapy June 28, 2021
Boehringer chases rival Merck KGaA with research into IAP cancer drugs June 25, 2021 By Richard Staines Boehringer Ingelheim GmbH has begun a three-year collaboration with researchers at Australia’s WEHI, looking into a potentially powerful approach to targeted protein degradation also being studied by its German rival Merck KGaA.Read More
Aravive advances phase Ib evaluation of AVB-500 with cabozantinib in clear cell renal cel carcinoma June 25, 2021
CStone reports data on Gavreto in Chinese patients with advanced RET fusion-positive NSCLC June 25, 2021
RSS